Bachem Holding AG (0QND)
LSE
Real-time Data
07:00 AM
Day's Range
79.0052 wk Range
48.70Overview - 0QND - Bachem Holding AG
Key Statistics
Valuation
Enterprise Value
6.10B
P/E (Trailing)
‪49.56‬
PEG Ratio
‪2.50‬
Price / Sales (TTM)
‪0.16‬
Price / Book
‪4.17‬
EV / EBITDA
‪29.01‬
Profitability
Gross Margin
‪69.98%‬
Profit Margin
‪21.02%‬
Operating Margin
‪16.58%‬
Return on Assets
‪4.54%‬
Return on Equity
‪10.62%‬
Ownership
Shares Outstanding
13.63M
Float
31.24M
Held by Insiders
‪0.24%‬
Held by Institutions
‪82.63%‬
Price stats
Beta
‪0.79‬
50-Day Avg
‪63.93‬
200-Day Avg
‪71.42‬
Dividends
Frequency
Annual
Market Cap - 0QND - Bachem Holding AG
Peers - 0QND - Bachem Holding AG
Peer Comparison
Compared with companies in Chemicals listed on LSE.
- 0QNDLSEBachem Holding AG1.06BMarket Cap+26.61%52-week change49.57P/E (Trailing)‪21.02%‬Profit Margin
- SGLDLSEInvesco Physical Gold ETC53.48BMarket Cap+4.58%52-week change-612.85P/E (Trailing)‪23.30%‬Profit Margin
- 0BFALSEBASF SE44.62BMarket Cap+11.85%52-week change200.00P/E (Trailing)‪0.32%‬Profit Margin
- 0HURLSECelanese Corp. Common Stock6.24BMarket Cap+12.48%52-week change0.02P/E (Trailing)‪-12.03%‬Profit Margin
- 0NZRLSESolvay SA2.75BMarket Cap-7.72%52-week change1.99P/E (Trailing)‪8.48%‬Profit Margin
- 0MGGLSEKemira Oyj2.60BMarket Cap-12.65%52-week change8.65P/E (Trailing)‪8.23%‬Profit Margin
- 0NZNLSERobertet SA1.71BMarket Cap-7.64%52-week change0.24P/E (Trailing)‪11.77%‬Profit Margin
Profile Summary - 0QND - Bachem Holding AG
About
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacturing of peptides and oligonucleotides for research, clinical development, and commercial applications. Founded in 1971 by Peter Grogg as Bachem Feinchemikalien AG in Liestal near Basel, it has grown into a global leader…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
